The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Open accessAbstract
Therapies targeting late events in Alzheimer’s disease (AD), including aggregation of amyloid beta (Aβ) and hyperphosphorylated tau, have largely failed, probably because they are given after significant neuronal damage has occurred. Biomarkers suggest that the earliest event in AD is a decrease of cerebral blood flow (CBF). This is caused by constriction of capillaries by contractile pericytes, probably evoked by oligomeric Aβ. CBF is also reduced by neutrophil trapping in capillaries and clot formation, perhaps secondary to the capillary constriction. The fall in CBF potentiates neurodegeneration by upregulating the BACE1 enzyme that makes Aβ and by promoting tau hyperphosphorylation. Surprisingly, therefore, CBF reduction may play a crucial role in driving cognitive decline by initiating the amyloid cascade itself, or being caused by and amplifying Aβ production. Here, we review developments in this area that are neglected in current approaches to AD, with the aim of promoting novel mechanism-based therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824 · cited 2×
“This flow may reach: (i) venules, where it helps to remove Aβ in the perivascular spaces of venules (in the same direction as CBF [73]), and (ii) the CSF and lymphatic vessels [6, 100, 103, 137].”
BackgroundAlzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,696
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543
Self-citationDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Subsequent work led to the conclusion that the level of soluble Aβ oligomers, and of hyperphosphorylation of the cytoskeletal protein tau that is induced by Aβ [62, 91], correlated better with cognitive decline than did plaque level [7, 57, 89, 123].”
BackgroundAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Molecular Architecture of the Mouse Nervous System
Zeisel, A., Hochgerner, H., Lönnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., Häring, M., Braun, E., Borm, L. E., La Manno, G., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.021 · Cited by 2,552
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Capillary pericytes regulate cerebral blood flow in health and disease
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870
Self-citationMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
Da Mesquita, S., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., Contarino, C., Onengut-Gumuscu, S., Farber, E., Raper, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0368-8 · Cited by 1,445
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328
Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., & Nedergaard, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-13.2013 · Cited by 1,319
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
Girouard, H., & Iadecola, C. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00966.2005 · Cited by 1,265
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
Bidirectional control of CNS capillary diameter by pericytes
Peppiatt, C. M., Howarth, C., Mobbs, P., & Attwell, D. (2006) · Nature · doi:10.1038/nature05193 · Cited by 1,150
Self-citationClusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Hanseeuw, B. J., Betensky, R. A., Jacobs, H. I. L., Schultz, A. P., Sepulcre, J., Becker, J. A., Cosio, D. M. O., Farrell, M., Quiroz, Y. T., Mormino, E. C., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1424 · Cited by 865
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Yemisci, M., Gursoy-Ozdemir, Y., Vural, A., Can, A., Topalkara, K., & Dalkara, T. (2009) · Nature Medicine · doi:10.1038/nm.2022 · Cited by 782
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Hill, R. A., Tong, L., Yuan, P., Murikinati, S., Gupta, S., & Grutzendler, J. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.001 · Cited by 722
Busche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206171109 · Cited by 715
Ma, Q., Ineichen, B. V., Detmar, M., & Proulx, S. T. (2017) · Nature Communications · doi:10.1038/s41467-017-01484-6 · Cited by 690
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., et al. (2019) · Science · doi:10.1126/science.aav9518 · Cited by 682
Self-citationWeller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00133.x · Cited by 681
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Attwell, D., Mishra, A., Hall, C. N., O’Farrell, F. M., & Dalkara, T. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610340 · Cited by 648
Self-citationHe, Z., Guo, J. L., McBride, J. D., Narasimhan, S., Kim, H., Changolkar, L., Zhang, B., Gathagan, R. J., Yue, C., Dengler, C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4443 · Cited by 645
A vicious cycle of β amyloid−dependent neuronal hyperactivation
Zott, B., Simon, M. M., Hong, W., Unger, F., Chen-Engerer, H.-J., Frosch, M. P., Sakmann, B., Walsh, D. M., & Konnerth, A. (2019) · Science · doi:10.1126/science.aay0198 · Cited by 640
Mehta, D., Jackson, R., Paul, G., Shi, J., & Sabbagh, M. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1323868 · Cited by 607
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 2×
“Importantly, ischaemia and hypoxia have been shown to upregulate the enzyme (BACE1) responsible for generating Aβ [168, 197], as schematised in Fig.”
BackgroundResultSmall, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
Peng, W., Achariyar, T. M., Li, B., Liao, Y., Mestre, H., Hitomi, E., Regan, S., Kasper, T., Peng, S., Ding, F., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.015 · Cited by 580
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555
Cruz Hernández, J. C., Bracko, O., Kersbergen, C. J., Muse, V., Haft-Javaherian, M., Berg, M., Park, L., Vinarcsik, L. K., Ivasyk, I., Rivera, D. A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0329-4 · Cited by 508
Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
Engler, R. L., Dahlgren, M. D., Morris, D. D., Peterson, M. A., & Schmid-Schonbein, G. W. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.251.2.h314 · Cited by 507
Morrison, H. W., & Filosa, J. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-4 · Cited by 506
Neurovascular and Cognitive Dysfunction in Hypertension: Epidemiology, Pathobiology, and Treatment
Iadecola, C., & Gottesman, R. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313260 · Cited by 502
Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain
Kisler, K., Nelson, A. R., Rege, S. V., Ramanathan, A., Wang, Y., Ahuja, A., Lazic, D., Tsai, P. S., Zhao, Z., Zhou, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4489 · Cited by 497
Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477 · cited 1×
“A major role for endothelial cell LRP1 in mediating Aβ export is shown by knock-out work [167], but astrocyte and neuronal LRP1 may also be involved [79, 96].”
BackgroundMadry, C., Kyrargyri, V., Arancibia-Cárcamo, I. L., Jolivet, R., Kohsaka, S., Bryan, R. M., & Attwell, D. (2018) · Neuron · doi:10.1016/j.neuron.2017.12.002 · Cited by 464
Self-citationDiagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria
Greenberg, S. M., & Charidimou, A. (2018) · Stroke · doi:10.1161/strokeaha.117.016990 · Cited by 439
Gauthier, S., Feldman, H. H., Schneider, L. S., Wilcock, G. K., Frisoni, G. B., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Wischik, D. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31275-2 · Cited by 427
Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway
Morizawa, Y. M., Hirayama, Y., Ohno, N., Shibata, S., Shigetomi, E., Sui, Y., Nabekura, J., Sato, K., Okajima, F., Takebayashi, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00037-1 · Cited by 415
Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
Busche, M. A., Wegmann, S., Dujardin, S., Commins, C., Schiantarelli, J., Klickstein, N., Kamath, T. V., Carlson, G. A., Nelken, I., & Hyman, B. T. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0289-8 · Cited by 413
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410
Can disturbed brain microcirculation cause Alzheimer’s disease?
de la Torre, J. C., & Mussivan, T. (1993) · Neurological Research · doi:10.1080/01616412.1993.11740127 · Cited by 365
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deußing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · doi:10.7892/boris.125653 · Cited by 352
Bosco, D. A., Fowler, D. M., Zhang, Q., Nieva, J., Powers, E. T., Wentworth, P., Lerner, R. A., & Kelly, J. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio782 · Cited by 349
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · cited 1×
“The upregulation of BACE1 by ischaemia and hypoxia occurs as a result of caspase-3 both increasing BACE1 mRNA level and cleaving GGA3, an adaptor protein involved in BACE1 trafficking, to decrease BACE1 degradation [171, 184, 194], and has two conceptual implications.”
Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., & Michiels, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300763200 · Cited by 316
Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls
Esparza, T. J., Zhao, H., Cirrito, J. R., Cairns, N. J., Bateman, R. J., Holtzman, D. M., & Brody, D. L. (2013) · Annals of Neurology · doi:10.1002/ana.23748 · Cited by 306
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
Mechanisms to explain the reverse perivascular transport of solutes out of the brain
Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., & Weller, R. O. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.07.005 · Cited by 293
Changes in Brain Function Occur Years before the Onset of Cognitive Impairment
Beason-Held, L. L., Goh, J. O., An, Y., Kraut, M. A., O'Brien, R. J., Ferrucci, L., & Resnick, S. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1402-13.2013 · Cited by 293
Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1
Kanekiyo, T., Cirrito, J. R., Liu, C.-C., Shinohara, M., Li, J., Schuler, D. R., Shinohara, M., Holtzman, D. M., & Bu, G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-13.2013 · Cited by 280
Less dementia with oral anticoagulation in atrial fibrillation
Friberg, L., & Rosenqvist, M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx579 · Cited by 279
Harkany, T., Ábrahám, I., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 273
Alarcon-Martinez, L., Yilmaz-Ozcan, S., Yemisci, M., Schallek, J., Kılıç, K., Can, A., Di Polo, A., & Dalkara, T. (2018) · eLife · doi:10.7554/elife.34861 · Cited by 270
The Role of Cdk5 in Alzheimer’s Disease
Liu, S.-L., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 269
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Liu, C.-C., Hu, J., Zhao, N., Wang, J., Wang, N., Cirrito, J. R., Kanekiyo, T., Holtzman, D. M., & Bu, G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3442-16.2017 · Cited by 267
Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides
Park, L., Uekawa, K., Garcia-Bonilla, L., Koizumi, K., Murphy, M., Pistik, R., Younkin, L., Younkin, S., Zhou, P., Carlson, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311054 · Cited by 259
Brickman, A. M., Provenzano, F. A., Muraskin, J., Manly, J. J., Blum, S., Apa, Z., Stern, Y., Brown, T. R., Luchsinger, J. A., & Mayeux, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1527 · Cited by 257
The capillary bed offers the largest hemodynamic resistance to the cortical blood supply
Gould, I. G., Tsai, P., Kleinfeld, D., & Linninger, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16671146 · Cited by 252
Kleinberger, G., Brendel, M., Mracsko, E., Wefers, B., Groeneweg, L., Xiang, X., Focke, C., Deußing, M., Suárez‐Calvet, M., Mazaheri, F., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796516 · Cited by 251
Kennedy, A. M., Frackowiak, R. S. J., Newman, S. K., Bloomfield, P. M., Seaward, J., Roques, P., Lewington, G., Cunningham, V. J., & Rossor, M. N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11270-7 · Cited by 250
Aβ1–40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation
Niwa, K., Younkin, L., Ebeling, C., Turner, S. K., Westaway, D., Younkin, S., Ashe, K. H., Carlson, G. A., & Iadecola, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9735 · Cited by 244
Vascular Compartmentalization of Functional Hyperemia from the Synapse to the Pia
Rungta, R. L., Chaigneau, E., Osmanski, B.-F., & Charpak, S. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.012 · Cited by 243
Li, Y., Li, Y., Li, X., Zhang, S., Zhao, J., Zhu, X., & Tian, G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169650 · Cited by 241
Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion
Mehta, J. L., Nichols, W. W., & Mehta, P. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90297-5 · Cited by 240
Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer’s disease
de la Monte, S. M. (1989) · Annals of Neurology · doi:10.1002/ana.410250506 · Cited by 229
Early Loss of Pericytes and Perivascular Stromal Cell-Induced Scar Formation after Stroke
Fernández-Klett, F., Potas, J. R., Hilpert, D., Blazej, K., Radke, J., Huck, J., Engel, O., Stenzel, W., Genové, G., & Priller, J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.187 · Cited by 229
Loss of Astrocyte Polarization in the Tg-ArcSwe Mouse Model of Alzheimer's Disease
Yang, J., Lunde, L. K., Nuntagij, P., Oguchi, T., Camassa, L. M. A., Nilsson, L. N. G., Lannfelt, L., Xu, Y., Amiry-Moghaddam, M., Ottersen, O. P., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110725 · Cited by 228
Wierenga, C. E., Hays, C. C., & Zlatar, Z. Z. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-141467 · Cited by 224
Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion
Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M., & Sadoshima, J. (2011) · Circulation Research · doi:10.1161/circresaha.111.249532 · Cited by 218
Niwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218
Hijazi, S., Heistek, T. S., Scheltens, P., Neumann, U., Shimshek, D. R., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0483-4 · Cited by 216
Mattsson, N., Tosun, D., Insel, P. S., Simonson, A., Jack, C. R., Beckett, L. A., Donohue, M., Jagust, W., Schuff, N., & Weiner, M. W. (2014) · Brain · doi:10.1093/brain/awu043 · Cited by 211
APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging
Thambisetty, M., Beason-Held, L., An, Y., Kraut, M. A., & Resnick, S. M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.913 · Cited by 209
Hladky, S. B., & Barrand, M. A. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0113-6 · Cited by 206
Aβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202
Cerebrovascular lesions induce transient -amyloid deposition
Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2011) · Brain · doi:10.1093/brain/awr300 · Cited by 187
Focal demyelination in Alzheimer’s disease and transgenic mouse models
Mitew, S., Kirkcaldie, M. T. K., Halliday, G. M., Shepherd, C. E., Vickers, J. C., & Dickson, T. C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0657-2 · Cited by 186
Hypertension and longitudinal changes in cerebral blood flow: The SMART‐MR study
Muller, M., van der Graaf, Y., Visseren, F. L., Mali, W. P. T. M., Geerlings, M. I., & for the SMART Study Group (2012) · Annals of Neurology · doi:10.1002/ana.23554 · Cited by 185
Smith, G. S. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530350056020 · Cited by 178
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot?
Panza, F., Lozupone, M., Seripa, D., & Imbimbo, B. P. (2019) · Annals of Neurology · doi:10.1002/ana.25410 · Cited by 178 · cited 1×
“Thirty years of research have given us a broad understanding of many mechanisms contributing to Alzheimer’s disease [99], but over 400 clinical trials of drugs targeting these pathways have largely failed to reduce cognitive decline [47, 109, 136].”
BackgroundSandsmark, D. K., Bashir, A., Wellington, C. L., & Diaz-Arrastia, R. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.002 · Cited by 178
Regional cerebral blood flow in Parkinson's disease with and without dementia
Firbank, M., Colloby, S. J., Burn, D. J., McKeith, I. G., & O'Brien, J. T. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00364-1 · Cited by 174
Cerebral Blood Flow Alterations in Acute Sport-Related Concussion
Wang, Y., Nelson, L. D., LaRoche, A. A., Pfaller, A. Y., Nencka, A. S., Koch, K. M., & McCrea, M. A. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4072 · Cited by 173
Smith, A. J., & Verkman, A. S. (2017) · The FASEB Journal · doi:10.1096/fj.201700999 · Cited by 173
Asllani, I., Habeck, C., Scarmeas, N., Borogovac, A., Brown, T. R., & Stern, Y. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600570 · Cited by 172
Abnormal Regional Cerebral Blood Flow in Cognitively Normal Elderly Subjects With Hypertension
Dai, W., López, O. L., Carmichael, O. T., Becker, J. T., Kuller, L. H., & Gach, H. M. (2008) · Stroke · doi:10.1161/strokeaha.107.495457 · Cited by 171
NADPH oxidases in Parkinson’s disease: a systematic review
Bélarbi, K., Cuvelier, E., Destée, A., Gressier, B., & Chartier‐Harlin, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0225-5 · Cited by 171
Querques, G., Borrelli, E., Sacconi, R., Vitis, L. A. D., Leocani, L., Santangelo, R., Magnani, G., Comı, G., & Bandello, F. M. (2019) · Scientific Reports · doi:10.1038/s41598-018-37271-6 · Cited by 165
Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
Wingo, A. P., Fan, W., Duong, D. M., Gerasimov, E. S., Dammer, E. B., Liu, Y., Harerimana, N. V., White, B., Thambisetty, M., Troncoso, J. C., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0635-5 · Cited by 161
Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance
Lei, M., Xu, H., Li, Z., Wang, Z., O'Malley, T. T., Zhang, D., Walsh, D. M., Xu, P., Selkoe, D. J., & Li, S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.019 · Cited by 161
Attems, J., Lintner, F., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0822-6 · Cited by 161
Age-dependent rescue by simvastatin of Alzheimer’s disease cerebrovascular and memory deficits
Tong, X.-K., Lecrux, C., & Hamel, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-12.2012 · Cited by 160
Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms
Mok, V. C. T., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, L. K. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.16 · Cited by 158
Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
Seo, J., Kritskiy, O., Watson, L. A., Barker, S. J., Dey, D., Raja, W. K., Lin, Y.-T., Ko, T., Cho, S., Penney, J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0621-17.2017 · Cited by 156
Wilhelmus, M. M. M., Otte-Höller, I., van Triel, J. J. J., Veerhuis, R., Maat-Schieman, M. L. C., Bu, G., de Waal, R. M. W., & Verbeek, M. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070050 · Cited by 138
Špiranec, K., Chen, W., Werner, F., Nikolaev, V. O., Naruke, T., Koch, F., Werner, A., Eder-Negrin, P., Diéguez-Hurtado, R., Adams, R. H., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033383 · Cited by 135
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1
D’haeseleer, M., Beelen, R., Fierens, Y., Cambron, M., Vanbinst, A., Verborgh, C., Mey, J. D., & Keyser, J. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222560110 · Cited by 135
Yew, B., Nation, D. A., & Initiative, F. T. A. D. N. (2017) · Brain · doi:10.1093/brain/awx112 · Cited by 133
Questions EMERGE as Biogen claims aducanumab turnaround
Howard, R., & Liu, K. Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0295-9 · Cited by 123
Masuda, T., Croom, D., Hida, H., & Kirov, S. A. (2011) · Glia · doi:10.1002/glia.21220 · Cited by 122
Zhang, X., Yin, X., Zhang, J., Li, A., Gong, H., Luo, Q., Zhang, H., Gao, Z., & Jiang, H. (2019) · National Science Review · doi:10.1093/nsr/nwz124 · Cited by 122
Mielke, R., Herholz, K., Grond, M., Kessler, J., & Heiß, W.-D. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106692 · Cited by 121
Review of ‘the Potential Role of Arterial Stiffness in the Pathogenesis of Alzheimer’s Disease’
Hughes, T. M., Craft, S., & López, O. L. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.53 · Cited by 121
Recovery of brain function during induced cerebral hypoperfusion
Marshall, R. S., Lazar, R. M., Pile-Spellman, J., Young, W. L., Duong, D. H., Joshi, S., & Ostapkovich, N. (2001) · Brain · doi:10.1093/brain/124.6.1208 · Cited by 120
Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.007 · Cited by 119
Cerebral perfusion as a diagnostic marker of early Alzheimer's disease
Prohovnik, I., Mayeux, R. P., Sackeïm, H. A., Smith, G. S., Stern, Y., & Alderson, P. O. (1988) · Neurology · doi:10.1212/wnl.38.6.931 · Cited by 118
Braide, M., AMUNDSON, B., Chien, S., & BAGGE, U. (1984) · Microvascular Research · doi:10.1016/0026-2862(84)90064-5 · Cited by 117
Qiu, L., Ng, G., Tan, E. K., Liao, P., Kandiah, N., & Zeng, L. (2016) · Scientific Reports · doi:10.1038/srep23964 · Cited by 115
Pathophysiology of Hypoperfusion of the Precuneus in Early A lzheimer's Disease
Miners, J. S., Palmer, J. C., & Love, S. (2015) · Brain Pathology · doi:10.1111/bpa.12331 · Cited by 115
Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo
Suo, Z., Humphrey, J., Kundtz, A., Sethi, F. N., Placzek, A. N., Crawford, F., & Mullan, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00814-3 · Cited by 114
Haft‐Javaherian, M., Fang, L., Muse, V., Schaffer, C. B., Nishimura, N., & Sabuncu, M. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213539 · Cited by 113
Cdk5: One of the links between senile plaques and neurofibrillary tangles?
Lee, M.-S., & Tsai, L. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5207 · Cited by 112
Liu, Q., Radwanski, R. E., Babadjouni, R., Patel, A. B., Hodis, D. M., Baumbacher, P., Zhao, Z., Zloković, B. V., & Mack, W. J. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17743670 · Cited by 111
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110
Amyloid Burden in Obstructive Sleep Apnea
Yun, C., Lee, H., Lee, S. K., Kim, H., Seo, H. S., Bang, S. A., Kim, S. E., Greve, D. N., Au, R., Shin, C., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161047 · Cited by 109
Park, J., Hong, J., Lee, S., Ji, H. D., Jung, J.-A., Yoon, K.-W., Lee, J.-I., Won, K. S., Song, B., & Kim, H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-50681-4 · Cited by 109
Zhiyou, C., Yong, Y., Shanquan, S., Jun, Z., Liangguo, H., Ling, Y., & Li, J. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9899-y · Cited by 107
Fülöp, G., Tarantini, S., Yabluchanskiy, A., Molnár, A., Prodan, C. I., Kiss, T., Csípő, T., Lipécz, Á., Balasubramanian, P., Farkas, E., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00776.2018 · Cited by 104
White matter capillaries in vascular and neurodegenerative dementias
Hase, Y., Ding, R., Harrison, G., Hawthorne, E., King, A., Gettings, S., Platten, C., Stevenson, W., Craggs, L. J. L., & Kalaria, R. N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0666-x · Cited by 101
Wang, X., Xing, A., Xu, C., Cai, Q., Liu, H., & Li, L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100216 · Cited by 98
Long-Term Dabigatran Treatment Delays Alzheimer’s Disease Pathogenesis in the TgCRND8 Mouse Model
Cortés‐Canteli, M., Kruyer, A., Fernandez‐Nueda, I., Marcos-Díaz, A., Cerón, C., Richards, A. T., Jno-Charles, O. C., Rodríguez, I., Callejas, S., Norris, E. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.081 · Cited by 98
Eskildsen, S. F., Gyldensted, L., Nagenthiraja, K., Nielsen, R. B., Hansen, M. B., Dalby, R. B., Frandsen, J. R., Rodell, A. B., Gyldensted, C., Jespersen, S. N., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.004 · Cited by 95
Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus
Fowler, J. C. (1990) · Brain Research · doi:10.1016/0006-8993(90)90560-x · Cited by 94
Expression and activity of β-site amyloid precursor protein cleaving enzyme in Alzheimer's disease
Johnston, J. A., Liu, W. W., Todd, S., Coulson, D. T. R., Murphy, S., Irvine, G. B., & Passmore, A. P. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051096 · Cited by 93
Dhiman, K., Gupta, V. B., Villemagne, V. L., Eratne, D., Graham, P. L., Fowler, C., Bourgeat, P., Li, Q., Collins, S., Bush, A. I., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12005 · Cited by 93
Increasing cerebral blood flow improves cognition into late stages in Alzheimer’s disease mice
Bracko, O., Njiru, B. N., Swallow, M. A., Ali, M. A., Haft‐Javaherian, M., & Schaffer, C. B. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19873658 · Cited by 92
High Activities of BACE1 in Brains with Mild Cognitive Impairment
Cheng, X., He, P., Lee, T., Yao, H., Li, R., & Shen, Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.002 · Cited by 90
Active role of capillary pericytes during stimulation-induced activity and spreading depolarization
Khennouf, L., Gesslein, B., Brazhe, A., Octeau, J. C., Kutuzov, N. P., Khakh, B. S., & Lauritzen, M. (2018) · Brain · doi:10.1093/brain/awy143 · Cited by 90
Arterial Pulsations cannot Drive Intramural Periarterial Drainage: Significance for Aβ Drainage
Diem, A. K., Sharp, M. M., Gatherer, M., Bressloff, N. W., Carare, R. O., & Richardson, G. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00475 · Cited by 87
Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction
Raz, L., Bhaskar, K., Weaver, J., Marini, S., Zhang, Q., Thompson, J. F., Espinoza, C., Iqbal, S., Maphis, N. M., Weston, L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.009 · Cited by 84
Roh, M., Eom, T.-Y., Zmijewska, A. A., Sarno, P. D., Roth, K. A., & Jope, R. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.039 · Cited by 83
Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease: A Randomized Trial
de Jong, D. L. K., de Heus, R. A. A., Rijpma, A., Donders, R. A. R. T., Rikkert, M. G. M. O., Günther, M., LAWLOR, B. A., van Osch, M. J. P., & Claassen, J. A. H. R. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12892 · Cited by 80
Collins-Praino, L. E., Francis, Y. I., Griffith, E. Y., Wiegman, A. F., Urbach, J., Lawton, A., Honig, L. S., Cortes, E., Vonsattel, J. P. G., Canoll, P. D., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0083-0 · Cited by 79
Susceptibility to capillary plugging can predict brain region specific vessel loss with aging
Schager, B., & Brown, C. E. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19895245 · Cited by 79
Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 76
Nelson, A. R., Sagare, M. A., Wang, Y., Kisler, K., Zhao, Z., & Zlokovic, B. V. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00108 · Cited by 73
Michels, L., Warnock, G., Buck, A., Macauda, G., Leh, S. E., Kaelin, A. M., Riese, F., Meyer, R., Tuura, R., Höck, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15605847 · Cited by 73
Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway
Casey, C. S., Atagi, Y., Yamazaki, Y., Shinohara, M., Tachibana, M., Fu, Y., Bu, G., & Kanekiyo, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625251 · Cited by 69
Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice
Pappolla, M., Sambamurti, K., Vidal, R., Pacheco-Quinto, J., Poeggeler, B., & Matsubara, E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.012 · Cited by 69
Ji, F., Pasternak, O., Ng, K. K., Chong, J. S. X., Liu, S., Zhang, L., Shim, H. Y., Loke, Y. M., Tan, B. Y., Venketasubramanian, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41363-2 · Cited by 58
Fazlollahi, A., Calamante, F., Liang, X., Bourgeat, P., Raniga, P., Doré, V., Fripp, J., Ames, D. J., Masters, C. L., Rowe, C. C., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26810 · Cited by 56
Murray, K. N., Girard, S., Holmes, W. M., Parkes, L. M., Williams, S. R., Parry‐Jones, A., & Allan, S. M. (2014) · Stroke · doi:10.1161/strokeaha.114.006613 · Cited by 53
Kimura, T., Hashimura, T., & Miyakawa, T. (1991) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1991.tb01189.x · Cited by 51
Proteostasis During Cerebral Ischemia
Thiebaut, A. M., Hedou, É., Marciniak, S. J., Vivien, D., & Roussel, B. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00637 · Cited by 51
The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes
Hansra, G. K., Popov, G., Banaczek, P. O., Vogiatzis, M., Jegathees, T., Goldsbury, C. S., & Cullen, K. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.009 · Cited by 51
Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
Lovell, M. A., Abner, E. L., Kryscio, R. J., Xu, L., Fister, S. X., & Lynn, B. C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/787805 · Cited by 50
Ito, S., Ueno, T., Ohtsuki, S., & Terasaki, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06708.x · Cited by 48
Disturbances in the control of capillary flow in an aged APPswe/PS1ΔE9 model of Alzheimer's disease
Gutiérrez‐Jiménez, E., Angleys, H., Rasmussen, P. M., West, M. J., Catalini, L., Iversen, N., Jensen, M. S., Frische, S., & Østergaard, L. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.006 · Cited by 44
Xiong, M., Zhang, T., Zhang, L., Lu, S.-D., Huang, Y.-L., & Sun, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.007 · Cited by 42
Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation
Norman, K. E., Cotter, M. J., Stewart, J. B., Abbitt, K. B., Ali, M., Wagner, B. E., Wallace, W. A., Forlow, S. B., & Hellewell, P. G. (2003) · Blood · doi:10.1182/blood-2001-12-0190 · Cited by 41
Rudinskiy, N., Grishchuk, Y., Vaslin, A., Puyal, J., Delacourte, A., Hirling, H., Clarke, P. G. H., & Luthi-Carter, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804740200 · Cited by 41
Sahathevan, R., Linden, T. K. A., Villemagne, V. L., Churilov, L. P., Ly, J. V., Rowe, C. C., Donnan, G. A., & Brodtmann, A. G. (2015) · Stroke · doi:10.1161/strokeaha.115.010528 · Cited by 41
Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia
Minami, M., Kimura, M., Iwamoto, N., & Arai, H. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00031-p · Cited by 40
Wu, C., & Wen, S. (2016) · Medicine · doi:10.1097/md.0000000000004593 · Cited by 40
Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis
Desai, R. A., Davies, A. L., Rossi, N. D., Tachrount, M., Dyson, A., Gustavson, B. P., Kaynezhad, P., MacKenzie, L. E., van der Putten, M. A., McElroy, D., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25749 · Cited by 38
Temporal Gene Expression Profiles after Focal Cerebral Ischemia in Mice
Zhang, C., Zhu, Y., Wang, S., Wei, Z. Z., Jiang, M. Q., Zhang, Y., Pan, Y., Tao, S., Li, J., & Wei, L. (2018) · Aging and Disease · doi:10.14336/ad.2017.0424 · Cited by 33
Guo, Y., Li, X., Zhang, M., Chen, N., Wu, S., Lei, J., Wang, Z., Wang, R., Wang, J., & Liu, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9950 · Cited by 31
Kwon, S., Moreno‐González, I., Taylor-Presse, K., Edwards, G. A., Gamez, N., Calderon, O., Zhu, B., Velasquez, F. C., Soto, C. A., & Sevick-Muraca, E. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190013 · Cited by 30
Love, S., & Miners, J. S. (2017) · Clinical Science · doi:10.1042/cs20170148 · Cited by 26
Abdullah, L. I., Crawford, F., Tsolaki, M., Börjesson‐Hanson, A., Rikkert, M. G. M. O., Pasquier, F., Wallin, A., Kennelly, S., Ait‐Ghezala, G., Paris, D., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00149 · Cited by 26
Yamada, M., Hayashi, H., Suzuki, K., Sato, S., Inoue, D., Iwatani, Y., Ohata, M., Yuan, B., & Takagi, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-48279-x · Cited by 22
Zhang, Y., Xiong, M., Yan, R., & Sun, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.228 · Cited by 21
Hypoperfusion of the motor cortex associated with parkinsonism in dementia with Lewy bodies
Takahashi, R., Ishii, K., Shimada, K., Ohkawa, S., & Nishimura, Y. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.033 · Cited by 18
Repurposing Antihypertensive Drugs for the Management of Alzheimer’s Disease
Law, C. S. W., & Yeong, K. Y. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200312114223 · Cited by 17
Li, R., He, Y.-S., Liu, M., Nie, Z., Huang, L., Lu, Z., Jin, L., & Li, Y. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s207069 · Cited by 11
Ortner, M., Hauser, C., Schmaderer, C., Muggenthaler, C., Hapfelmeier, A., Sorg, C., Diehl‐Schmid, J., Kurz, A., Förstl, H., Ikenberg, B. D., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225754 · Cited by 7
Cited by
Tsartsalis, S., Sleven, H., Fancy, N., Wessely, F., Smith, A. M., Willumsen, N., Cheung, T. K. D., Rokicki, M. J., Chau, V., Ifie, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46630-z · Cited by 95
Morató, X., Pytel, V., Jofresa, S., Ruiz, A., & Boada, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169305 · Cited by 53
“Novel strategies are currently under development to increase the BBB penetrance of mAbs.”
BackgroundInfluentialTarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
Babateen, A. M., Shannon, O. M., O’Brien, G. M., Okello, E., Smith, E., Olgacer, D., Koehl, C., Fostier, W., Wightman, E., Kennedy, D., et al. (2022) · Nutrients · doi:10.3390/nu14051052 · Cited by 20
“Lowered CBF is widely acknowledged as a key contributor to cognitive decline [48,49].”
BackgroundPrimary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease
Sunderman, C. L., Forero, K. V., Alorjani, Q., Buqaileh, R., Gallagher, G. M., Ventresca, S. M., Messer, W. S., & AbouAlaiwi, W. A. (2025) · Brain Sciences · doi:10.3390/brainsci15091004 · Cited by 1
“The reduction in CBF is suggested to start early in preclinical AD, along with a fall in metabolism [96].”
Influential
Metadata
- Authors
- Korte, N., Nortley, R., & Attwell, D.
- Venue
- Acta Neuropathologica
- Published
- 2020-08-31
- Volume
- 140
- Issue
- 6
- Pages
- 793-810
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W3081828988
- Cited by
- 350
- References
- 196
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.